Theabrownin

Theabrownin: A Comprehensive Reference

1. Identity, Chemistry, and Natural Sources

1.1 Nomenclature and Classification

Theabrownin (commonly abbreviated TB; also rendered in the plural as theabrownins or TBs) is the accepted common name for a family of high-molecular-weight polymeric pigments found predominantly in fermented or post-fermented teas. The compound has no single IUPAC name because it is not a discrete molecule; it is instead a heterogeneous mixture of macromolecular polymers. Theabrownins are a type of brown or reddish-brown pigment that are soluble in water but are insoluble in ethyl acetate, n-butyl alcohol, or other organic solvents.

Theabrownins are heterogeneous macromolecules that are polymerized, condensed, coupled, and oxidized from catechins, theaflavins, and thearubigins with other compounds, such as proteins, lipids, polysaccharides, and other components. Structural studies reveal theabrownin as a polymer with an average molecular weight of approximately 6,200, characterized by hydroxyl and carboxyl groups.

Theabrownins are water-soluble polyphenol polymers that are oxidized from catechins, and their gallate derivatives are derived throughout the dark tea fermentation process. Numerous studies have indicated that TBs contain a large number of complex heterogeneous components, including carbohydrates, proteins, flavonoids, and other ingredients.

1.2 Structural Characteristics

Because of their condensed nature, the molecules of theabrownins cannot be easily separated by chemical methods; the structural characteristics of theabrownins remain unclear, and thus their applications remain limited. The molecular weights and the different sources of theabrownins have an impact on their structure and composition.

Ultraviolet–visible spectrophotometry (UV-Vis) and Fourier transformation infrared spectroscopy (FT-IR) show that theabrownins are polymerized phenolic substances containing abundant hydroxy and carboxyl groups. Pyrolysis-GC/MS analysis has identified 83 pyrolysis products from theabrownin, including esters, aldehydes, and phenols.

The main constituents of theabrownin are polyphenols and products of oxidative polymerization of polyphenols with caffeine, proteins, sugars, and amino acids. One study of Tibetan tea theabrownin identified primary hydrolysis constituents including jaceosidin, triethyl citrate, α-naphthoflavone, epicatechin, quercetin, and apigenin 7-rutinoside.

Studies using scanning electron microscopy (SEM) have characterized TBs as amorphous, thermostable polymers with a slice-shaped and smooth surface, while atomic force microscopy (AFM) shows an island-like structure resulting from aggregation of theabrownin molecules.

1.3 Natural Sources and Tea Types

Theabrownins are exclusively produced during the microbial fermentation of tea leaves. Theabrownins are the major bioactive components of dark tea such as Pu-erh tea, Chin-brick tea, Fu-brick tea, and Liu Bao tea. Dark tea is a typical post-fermented tea in China, including Yunnan Pu-erh tea, Hunan Fu-brick tea, Shaanxi Fu-brick tea, Hubei Qing-brick tea, Sichuan Kang-brick tea, and Guangxi Liu-bao tea.

The botanical raw material for all of these teas is Camellia sinensis. Pu-erh tea is made from the leaves of the Yunnan tea plant Camellia sinensis var. assamica, a specific variety of tea plant native to Yunnan.

Theabrownins accumulate progressively as fermentation proceeds. Total phenolics, flavonoids, theaflavins, thearubigins, and galloyl catechins consistently decrease during solid-state fermentation, whereas theabrownins continually increase. The key fungal agents responsible for this transformation are well characterized: Eurotium cristatum is the predominant fungus and key contributor to the characteristics of post-fermented Fu brick tea (FBT) during manufacturing. E. cristatum is specifically favorable to the accumulation of theabrownins during solid-state fermentation of dark tea.

Detailed fermentation data indicate the scale of production: in an artificial solid-state fermentation, green tea leaves inoculated with E. cristatum spores (2 × 10⁴ CFU per gram) at 28 °C and 70% humidity for 12 days resulted in TBs production reaching approximately 175 g kg⁻¹.

2. Traditional and Historical Use

2.1 Pu-erh and Dark Tea in Chinese Tradition

Theabrownin was not identified or named as a distinct compound until the modern era of analytical chemistry, but the teas that are its richest sources have been used in Chinese medical and cultural traditions for many centuries. Pu-erh tea has been used for thousands of years to treat metabolic diseases. Recognized in Shen Nong's Herbal Classic, a compendium kept by the first traditional Chinese practitioners, it is still highly valued for its hypocholesterolemic and hypolipidemic effects.

Historically, Pu-erh tea was named after the city of Pu'er, a trading hub during the Tang Dynasty (618–907 CE). Merchants transported compacted tea along the ancient Tea Horse Road, a network of trade routes that connected China to Tibet, Southeast Asia, and beyond. This method of trade not only expanded the tea's popularity but also allowed the tea to age and develop its characteristic flavor.

The Pu'er Traditional Tea Agroecosystem is a Globally Important Agricultural Heritage System (GIAHS) that was recognized by the Food and Agriculture Organization (FAO) of the United Nations in August 2012.

In the context of Traditional Chinese Medicine (TCM), Pu-erh tea has a warming and potent digestive property; Chinese doctors consider Pu-erh as a tea that dispels or cleanses the body of fat and toxins from meat and oily foods.

2.2 Forms Used Traditionally

Pu-erh is sold in two main categories: sheng (raw) and shou (ripe). Sheng Pu-erh is the traditional form, designed to age slowly over years and decades, while shou Pu-erh is a modern invention that accelerates the fermentation process to produce a darker, mellower tea in a matter of weeks.

Traditional preparations consisted primarily of compressed cakes or bricks steeped in hot water as a beverage. In the context of traditional Chinese tea production terminology, fermentation refers to microbial fermentation (called "wet piling"), and is typically applied after the tea leaves have been sufficiently dried and rolled. As the tea undergoes controlled microbial fermentation, it also continues to oxidize, which is controlled, until the desired flavors are reached.

3. Key Constituents and Established Mechanisms of Action

3.1 Constituent Chemistry

Through fermentation, catechins, the main active derivative of polyphenols, are oxidized into complex tea pigments. Tea pigments are composed of theaflavin (TF), thearubigin (TR), and theabrownin (TB). Theabrownins represent the final, most heavily oxidized and polymerized stage in this progression. Theabrownins (TBs), the main bioactive polymeric pigments found in dark tea, have received increasing attention for their health effects.

3.2 Gut Microbiota Modulation and Bile Acid Metabolism (Best-Established Mechanism)

The most thoroughly characterized mechanism by which theabrownin exerts systemic metabolic effects involves reshaping the composition of the gut microbiome and, consequently, the metabolism of bile acids. Pu-erh tea displays cholesterol-lowering properties, but the underlying mechanism had not been fully elucidated until recently. Theabrownin is one of the most active and abundant pigments in Pu-erh tea. Studies show that theabrownin alters the gut microbiota in mice and humans, predominantly suppressing microbes associated with bile-salt hydrolase (BSH) activity.

The cascade initiated by BSH suppression is well described: Theabrownin increases the levels of ileal conjugated bile acids (BAs), which, in turn, inhibit the intestinal FXR-FGF15 signaling pathway, resulting in increased hepatic production and fecal excretion of BAs, reduced hepatic cholesterol, and decreased lipogenesis. The inhibition of intestinal FXR-FGF15 signaling is accompanied by increased gene expression of enzymes in the alternative BA synthetic pathway, production of hepatic chenodeoxycholic acid, activation of hepatic FXR, and hepatic lipolysis.

Additional mechanistic work has further detailed the anti-adipogenic arm of this pathway: Theabrownin remodels gut microbiota structure in a high-fat diet (HFD)-induced obesity state by elevating the abundance of 7α-dehydroxylation-rich microbes, including Clostridium scindens and Parabacteroides distasonis, which, in turn, resulted in increased levels of ursodeoxycholic acid (UDCA), CDCA, and LCA in the intestine. The beneficial effects of theabrownin were confirmed to operate in a gut microbiome-dependent manner through fecal microbiota transplant (FMT) validation.

3.3 Hepatic Lipid Metabolism Pathways

Theabrownin significantly ameliorates dyslipidemia, hepatic steatosis, and systemic inflammation induced by a high-fat/high-cholesterol diet (HFD) in animal models. In studies using HFD-obese mice, serum total triglycerides, total cholesterol, and low-density lipoprotein cholesterol, as well as activities of aspartate aminotransferase and alanine aminotransferase, were decreased; protein and mRNA expression of fatty acid synthesis and lipid production-related genes were also downregulated.

Mechanistic studies further show that after theabrownin administration, hepatic bile acid synthesis shifts from the classic pathway to predominantly the alternative pathway, resulting in a modified 12OH-BAs/non-12OH-BAs ratio in the liver and serum. The liver enzyme CYP7B1 appears to be a critical mediator: hepatic AAV-shRNA knockdown of CYP7B1 eliminated the cholesterol-lowering effects of Pu-erh tea and theabrownin, while theabrownin still could lower the cholesterol level in hepatic AAV-shRNA knockdown of CYP7A1, indicating that the major cholesterol-lowering effects of Pu-erh tea and theabrownin are due to elevated CYP7B1 expression.

3.4 Anti-Obesity Mechanisms

Animal studies show that theabrownin significantly reduced body weight gain (83.0%) and body fat accumulation (30.29%) without affecting appetite, while also promoting lipid clearance with a hepatoprotective effect. The extra addition of antibiotics disrupted the regulation of theabrownin on weight control, while fecal microbiota transplant restored the beneficial regulation, confirming that gut microbiota is important for theabrownin to reduce body weight gain.

At the metabolomics level, 18 metabolites were found to be related to the anti-obesity effect of theabrownin mediated by gut microbiota, and phenylalanine metabolism, histidine metabolism, as well as protein digestion and absorption pathways played a role in the anti-obesity effects of theabrownin.

Energy expenditure in adipose tissue appears to be another arm of the anti-obesity mechanism: host energy metabolism after theabrownin intervention has been found to improve by examining the mRNA expression levels of UCP1 and peroxisome proliferator-activated receptor-gamma coactivator α (PGC1α) in adipose tissue.

3.5 Anticancer Signaling Pathways

Theabrownins impart dark tea with distinct biological activities, including antioxidant, anti-inflammatory, antimicrobial, and anticancer effects. In cancer cell biology, multiple signaling cascades have been implicated.

Against non-small cell lung cancer (NSCLC): Theabrownins inhibit proliferation, promote apoptosis, and induce G1 cell-cycle arrest in lung cancer cells. They increase autophagic flux, which in turn promotes the death of lung cancer cells. Additionally, theabrownins suppress PI3K/AKT/mTOR pathway activation and promote autophagy.

Against hepatocellular carcinoma (HCC): TB up-regulates the gene expressions of NOXA, PUMA, P21, Bax, and Bim, and up-regulates the protein expressions of ASK-1, Bax, phosphorylated JNK, and phosphorylated c-Jun, with down-regulation of Bcl-2. The JNK inhibitor significantly weakened TB's effects both in vivo and in vitro; TB exerts anti-proliferative, pro-apoptotic, and tumor-inhibitory effects on Huh7 hepatocellular carcinoma cells through activation of the JNK signaling pathway.

Theabrownin has previously been reported to have antitumor effects on non-small-cell lung cancer, osteosarcoma, hepatocellular carcinoma, gliomas, and melanoma. Consistent tumor-suppressive effects of TB have been found across different research groups utilizing TB from different sources, through modulating oncogenic pathways including PI3K/Akt, p53/JNK, and NF-κB.

4. Scientific Evidence by Area of Use

4.1 Lipid Metabolism and Hypercholesterolemia

This is the area with the strongest body of published evidence, including data from both animal models and human subjects.

Human and combined human/mouse data: The most frequently cited study was published in Nature Communications (2019) and involved both murine and human components. Pu-erh tea was found to lower triglyceride (TG) and total cholesterol (TC) levels more significantly than green, oolong, or black teas, and mice and human subjects receiving Pu-erh tea exhibited significant decreases in hepatic and serum cholesterol levels. Changes in lipids induced by Pu-erh tea were confirmed by the reduction of serum TC and TG in human subjects, showing the preventive effect of Pu-erh tea consumption on hyperlipidemia.

Animal models: Theabrownin significantly ameliorated dyslipidemia, hepatic steatosis, and systemic inflammation induced by a high-fat/high-cholesterol diet and significantly improved HFD-induced gut microbiota dysbiosis in rodent studies. After TB treatment, body weight, blood, and liver lipid levels were reduced in both humans and mice, as established in prior published work.

Evidence characterization: The human component of the key 2019 Nature Communications study was limited in scope and served primarily to confirm microbiota shifts observed in mice. The body of evidence is predominantly derived from animal models and mechanistic studies. Large-scale, prospectively registered, randomized controlled trials (RCTs) investigating theabrownin as an isolated intervention in humans have not yet been published as of the time of this article.

4.2 Obesity and Body Weight Regulation

Non-alcoholic fatty liver disease (NAFLD) with obesity seriously threatens public health. Prior studies showed that dark tea had more potential for regulating lipid metabolism than other teas, and theabrownin was considered to be a main contributor to the bioactivity of dark tea.

In a murine HFD model, theabrownin was administered and outcomes measured over 8 weeks: male C57BL/6 J mice were fed with a high-fat diet (HFD group) or HFD with theabrownin for 8 weeks. After 8 weeks, body weights in the HFD group climbed progressively, while those in the HFD + TB group slightly increased with significantly lower body weights on the 7th and 8th weeks. Decreased liver weights indicated the amelioration of excessive hepatic lipid storage.

A further study of theabrownin from Wuniuzao dark tea found that theabrownin from Wuniuzao dark tea achieved liver protection and anti-obesity effects by regulating the SREBP lipid metabolism pathway and bile acid metabolism process, and improving the gut microbiota composition of mice.

Evidence characterization: Evidence in the obesity domain is entirely preclinical (rodent models and zebrafish models). Fecal microbiota transplant experiments provide mechanistic validation of gut microbiota dependence. No published controlled human trials directly measuring body weight or adiposity as primary outcomes for theabrownin as an isolated extract exist.

4.3 Non-Alcoholic Fatty Liver Disease (NAFLD / MASLD)

Multiple studies have investigated theabrownin's impact on hepatic lipid accumulation and liver function markers. The body weight and epididymis fat weight of obese mice fed with theabrownin were decreased; serum total triglycerides, total cholesterol, low-density lipoprotein cholesterol, and activities of aspartate aminotransferase and alanine aminotransferase were also decreased.

The combination of theabrownin with Poria cocos polysaccharide has also been examined: a comparison of individual TB or PCP and the combination of TB and PCP on NAFLD phenotypes in HFD-fed mice showed that TB, PCP, and TB + PCP all reduced serum and hepatic lipid levels, with the combination being most effective.

Research into theabrownin's effect on MASLD (metabolic dysfunction-associated steatotic liver disease) via intestinal microbiota modulation has also been conducted: findings highlight the possible mechanisms of theabrownin from Qingzhuan tea in improving hepatic lipid metabolism and anti-obesity, suggesting it may be a potential therapeutic agent for obesity-induced MASLD.

Evidence characterization: Preclinical (murine) only. No human clinical trials on theabrownin and NAFLD/MASLD have been published.

4.4 Oncology (Preclinical Evidence Only)

All evidence in the cancer domain is derived from in vitro cell-line studies and animal xenograft models. No human clinical evidence exists.

Lung cancer: A study aimed to determine the in vitro and in vivo anti-lung cancer effect of TB and explore the underlying molecular mechanism, using the A549 cell line and Lewis lung carcinoma-bearing mice. The in vivo data verified the in vitro result that TB could significantly inhibit lung cancer growth in mice and induce apoptosis on tumors in a dose-dependent manner. A separate 2022 study showed that chemically oxidized theabrownins demonstrated stronger inhibition than tea polyphenols on NSCLC cell lines A549, H2030, HCC827, H1975, and PC9.

Hepatocellular carcinoma: In vivo data showed that TB exerted a significant tumor-inhibitory effect in Huh7 cell xenograft zebrafish models which was even stronger than that of cis-platinum.

Colorectal cancer: Colorectal cancer (CRC) is one of the most common and fatal cancers worldwide. Theabrownin, an antioxidant from Pu-erh tea, has been reported to have antitumor effects on non-small-cell lung cancer, osteosarcoma, hepatocellular carcinoma, gliomas, and melanoma. Preclinical murine AOM/DSS model research investigated its potential against colorectal tumorigenesis.

Evidence characterization: All oncology evidence is strictly preclinical (cell lines and animal xenograft models). These findings establish biological plausibility but cannot be extrapolated to clinical efficacy or safety in human cancer treatment.

4.5 Antioxidant Activity

Theabrownins impart dark tea with distinct biological activities, including antioxidant effects. Theabrownin is described as an antioxidant from Pu-erh tea in peer-reviewed literature, and antioxidant properties have been consistently demonstrated in cell-free assays and cell culture models. The antioxidant activity of fermented dark teas has been linked specifically to their polyphenolic composition, of which theabrownins are the dominant fraction. Fermentation of Fu brick tea using Eurotium cristatum has found that fermented tea at 28 and 37°C has strong antioxidant capacity.

Evidence characterization: Antioxidant activity has been well-demonstrated in vitro and in animal models. Human data specific to the isolated theabrownin fraction are not established in controlled trials.

4.6 Gut Microbiome Modulation (Prebiotic-Like Activity)

Prior research has unveiled the prebiotic-like properties of theabrownin, and subsequent studies have aimed to further investigate the theabrownin–gut microbiota interactions and their downstream effects on lipid metabolism using integrated physiological, genomic, metabolomic, and transcriptomic approaches.

TB has been proven to exert modulatory effects on gut microbiota and promote production of short-chain fatty acids (SCFAs) in mice fed with a high-fat diet. The human component of the 2019 Nature Communications study provided direct evidence that theabrownin shifts the composition of the human gut microbiome, predominantly reducing BSH-associated microbial populations.

Evidence characterization: Mechanistically well-supported in animal models, with limited (but present) human microbiota data. Long-term human clinical evidence for prebiotic efficacy is lacking.

5. Body Systems and Health Areas Associated with Theabrownin

• Cardiovascular / Lipid Metabolism: Reduction of serum total cholesterol, triglycerides, and LDL-C; decreased hepatic lipogenesis via bile acid pathway modulation.
• Gastrointestinal / Gut Microbiome: Prebiotic-like modulation of gut microbiota composition; promotion of short-chain fatty acid production; suppression of BSH-active bacteria.
• Hepatic: Reduction of hepatic steatosis, liver fat accumulation, and liver enzyme elevations (ALT, AST) in animal models of NAFLD.
• Adipose / Body Composition: Anti-adipogenic effects mediated through bile acid–TGR5 axis and energy expenditure in adipose tissue in preclinical models.
• Oncological (preclinical only): In vitro and xenograft model activity against lung, hepatocellular, colorectal, osteosarcoma, glioma, and melanoma cell lines.
• Antioxidant: Free radical scavenging activity demonstrated in laboratory assays and fermentation studies.

6. Dosage Forms and Doses Reported in Research

Theabrownin is not currently available as a regulated, standardized dietary supplement with established serving sizes. The following doses have been reported specifically in published peer-reviewed studies:

• Doses of either 50 or 450 mg/kg/day of Pu-erh tea (containing theabrownin as an active fraction) were used in murine treatment experiments.
• In a lung cancer xenograft murine model, oral administration of low-dose theabrownins (150 mg/kg/day) and high-dose theabrownins (300 mg/kg/day) for 28 days resulted in significantly decreased average tumor volume and weight compared with controls.
• In a safety study using a high-theabrownin black tea extract (Herbt Tea Essences), the median lethal dose (LD₅₀) value was 21.68 g/kg (21.06–24.70 g/kg, greater than 5 g/kg), and no abnormal effects were observed in the 40 and 400 mg/kg/day groups over 28 days.
• When mice were administered theabrownin at 150–300 mg/kg/day, no significant pathological abnormalities occurred in major organs including the heart, brain, and kidney.

No human dose-ranging or pharmacokinetic trials for isolated theabrownin have been published in the peer-reviewed literature. The human studies that do exist investigated whole Pu-erh tea consumption rather than isolated theabrownin at a specified dose.

7. Safety Considerations

7.1 Preclinical Toxicology

A deep-processed black tea extract with a high content of TB (close to 80%), named Herbt Tea Essences (HTE), was prepared, and a study was designed to evaluate the biosafety of high-content TB products in mice using acute and subacute toxic experiments. The median lethal dose (LD₅₀) value was found to be 21.68 g/kg, suggesting low acute toxicity. In the 28-day subacute exposure study, no abnormal effects were observed in the 40 and 400 mg/kg/day HTE-treated groups.

7.2 Absence of Robust Human Safety Data

Robust clinical studies, alongside comprehensive toxicological evaluations, are warranted to confirm the safety and efficacy of theabrownins for long-term use. Interpreting the metabolic pathways in the body and defining the metabolites of TBs in vitro and in vivo are critically important for correlating the known bioactivities. Future research should prioritize the design of well-controlled clinical trials to validate the safety, efficacy, and optimal dosage of TBs in human populations, particularly for managing metabolic disorders, inflammation, and cancer risk.

7.3 Structural Heterogeneity as a Safety Variable

The molecular weights and the different sources of theabrownins have an impact on their structure and composition, meaning that theabrownin preparations from different tea sources (e.g., Pu-erh versus Fu brick versus Tibetan tea) are not chemically equivalent. This structural heterogeneity complicates both the characterization of safety and the extrapolation of findings from one preparation to another. Theabrownins prepared from dark tea contain a large number of complex heterogeneous components, such as carbohydrates, proteins, and flavonoids, which are difficult to remove. Additionally, some toxic and harmful extraction solvents are used to purify TBs, which hinder the utilization and industrialization of TBs.

7.4 Caffeine Content of Source Teas

As theabrownin is invariably obtained from or associated with fermented tea preparations, any whole-tea product used as a source will also contain caffeine. Purine alkaloids, including caffeine, are significantly increased in dark tea following fermentation compared to green tea, which is a relevant consideration for individuals sensitive to methylxanthines, although this applies to whole tea consumption rather than to isolated theabrownin extracts specifically.

7.5 Current Evidence Gap

As of the present date, there are no published long-term human safety studies for isolated theabrownin as a dietary supplement. All published toxicological data are from murine models. The compound's heterogeneous macromolecular structure poses significant challenges for standardization of both dosing and quality control in any supplemental form. Reviewers in the field have explicitly identified the need for comprehensive toxicological evaluation before theabrownin's full potential as a functional food ingredient can be realized.

References

• Structural Characteristics and Hypolipidemic Activity of Theabrownins from Dark Tea Fermented by Single Species Eurotium cristatum PW-1 — PMC / Nutrients (2020)
• Comprehensive characterization of theabrownin polymer structure in Tibetan tea — ScienceDirect / Industrial Crops and Products (2023)
• Comprehensive Analysis of Theabrownin Structure in Tibetan Tea — SSRN preprint (2023)
• Theabrownins Produced via Chemical Oxidation of Tea Polyphenols Inhibit Human Lung Cancer Cells in vivo and in vitro by Suppressing the PI3K/AKT/mTOR Pathway — Frontiers in Nutrition (2022)
• Theabrownin from Pu-erh tea attenuates hypercholesterolemia via modulation of gut microbiota and bile acid metabolism — Nature Communications (2019)
• Theabrownin from Pu-erh tea attenuates hypercholesterolemia via modulation of gut microbiota and bile acid metabolism — PMC full text (2019)
• Theabrownin from Pu-erh tea attenuates hypercholesterolemia via modulation of gut microbiota and bile acid metabolism — PubMed abstract (2019)
• Anti-Adipogenic Effect of Theabrownin Is Mediated by Bile Acid Alternative Synthesis via Gut Microbiota Remodeling — PMC (2020)
• Anti-Obesity Effect of Theabrownin from Dark Tea in C57BL/6J Mice Fed a High-Fat Diet by Metabolic Profiles through Gut Microbiota Using Untargeted Metabolomics — PMC (2022)
• Theabrownin inhibits obesity and non-alcoholic fatty liver disease in mice via serotonin-related signaling pathways and gut-liver axis — PubMed (2023)
• Theabrownin and Poria cocos Polysaccharide Improve Lipid Metabolism via Modulation of Bile Acid and Fatty Acid Metabolism — Frontiers in Pharmacology (2022)
• Theabrownin Alleviates Colorectal Tumorigenesis in Murine AOM/DSS Model via PI3K/Akt/mTOR Pathway Suppression and Gut Microbiota Modulation — PMC / Antioxidants (2022)
• Theabrownin Inhibits Cell Cycle Progression and Tumor Growth of Lung Carcinoma through c-myc-Related Mechanism — PMC / Frontiers in Pharmacology (2017)
• Theabrownin Induces Apoptosis and Tumor Inhibition of Hepatocellular Carcinoma Huh7 Cells Through ASK1-JNK-c-Jun Pathway — PMC / OncoTargets and Therapy (2020)
• Acute and Subacute Safety Evaluation of Black Tea Extract (Herbt Tea Essences) in Mice — PMC (2022)
• Theabrownins Produced via Chemical Oxidation of Tea Polyphenols Inhibit Human Lung Cancer Cells in vivo and in vitro — PMC full text (2022)
• Characterization of Theabrownins Prepared From Tea Polyphenols by Enzymatic and Chemical Oxidation and Their Inhibitory Effect on Colon Cancer Cells — Frontiers in Nutrition (2022)
• Theabrownins from dark tea: formation, gut microbiota-mediated biotransformation, health benefits, and potential in functional food applications — Food & Function, RSC Publishing (2025)
• Pu-erh tea: A review of a healthful brew — ScienceDirect / Journal of Traditional Chinese Medical Sciences (2022)
• Chemical compositions of Pu'er tea fermented by Eurotium cristatum and their lipid-lowering activity — ScienceDirect / LWT Food Science and Technology (2018)
• UPLC–QQQ–MS/MS-based widely targeted metabolomic analysis reveals the effect of solid-state fermentation with Eurotium cristatum on dark tea — ScienceDirect / Food Chemistry (2022)
• Theabrownin from Wuniuzao Dark Tea Regulates Hepatic Lipid Metabolism and Gut Microbiota in Mice Fed High-Fat Diet — PMC (2023)
• Theabrownin from Qingzhuan tea prevents high-fat diet-induced MASLD via regulating intestinal microbiota — ScienceDirect (2024)
• Theabrownin as a Potential Prebiotic Compound Regulates Lipid Metabolism via the Gut Microbiota, Microbiota-Derived Metabolites, and Hepatic FoxO/PPAR Signaling Pathways — Journal of Agricultural and Food Chemistry (2024)
• Pu'er tea — Wikipedia
• Traditional management of ancient Pu'er teagardens in Jingmai Mountains in Yunnan of China — PMC (2023)
• Modulation effects of microorganisms on tea in fermentation — PMC / Frontiers in Nutrition (2022)